Status:

RECRUITING

Amino Acids in Patients With Anorexia Nervosa: Double-blind Randomized Study Versus Placebo

Lead Sponsor:

Villa Garda Hospital

Collaborating Sponsors:

University of Milan

Università degli Studi di Brescia

Conditions:

Anorexia Nervosa

Eligibility:

All Genders

16-50 years

Phase:

NA

Brief Summary

Amino acids (AAs) are crucial for protein synthesis, in influencing nutritional status, as sources of vital elements (e.g., nucleotides, neurotransmitters) and as signal molecules for the modulation o...

Detailed Description

Nutrition is one of the main determinants of health. Among the three primary macronutrients, proteins - specifically, their quantity and quality (i.e., their specific amino acid profile) - play a cruc...

Eligibility Criteria

Inclusion

  • Diagnosis of anorexia nervosa
  • Age between 16 and 50 years
  • Written informed consent

Exclusion

  • Schizophrenia or other psychotic disorders
  • Diagnosis of bulimia nervosa
  • Current and ongoing substance use disorder
  • Medical complications capable of hindering the interpretation of the results (e.g. a a medical disease that induces weight loss)
  • Presence of physical treatments (including drugs) hindering the interpretation of the results (e.g. chemotherapy for cancer)
  • Being pregnant or intending to become pregnant during treatment

Key Trial Info

Start Date :

July 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2027

Estimated Enrollment :

92 Patients enrolled

Trial Details

Trial ID

NCT05290285

Start Date

July 1 2022

End Date

January 1 2027

Last Update

September 5 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Eating and Weight Disorders, Villa Garda Hospital

Garda, Italy, Italy, 37016